Norm Kumar, CFA
Veteran Analyst, Technology & Healthcare
Norm has over 20 years of investment experience in both private and public equity. Presently, he is a Senior Healthcare & Technology Analyst for the Pennock Idea Hub. At PIH, he provides independent research to Institutional clients on topics within the healthcare and technology spheres covering individual stocks as well as writing about emerging technologies such as AI and a soon to be released report on CRISPR. We not only generate our own ideas but produce bespoke research for clients to assist them in analyzing situations of interest. Norm also works with the White Owl family office to assist them in assessing potential private equity investments within the healthcare field, particularly drug and device companies. Prior to PIH, Norm served as a Sr Investment Consultant to XPV Water Partners where he assisted them in deal analysis and execution for their existing portfolio and new investments. Earlier in his career, he was a Portfolio Manager and CIO at two hedge funds, Radiant & K2, with primary responsibility for the healthcare and technology investments. Additionally, he was a senior investment professional at two prominent Canadian Venture Capital/Private Equity funds (CIBC Capital Partners and Working Ventures Canadian Fund) where he had responsibility for direct investments. He has served on numerous Boards over the years. Norm tries to bring the discipline of private equity analysis to public market investment assessments to assist clients to make meaningful risk-reward decisions.